Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …

Most cancer drugs are designed to interfere with one or more events in cell proliferation or
survival. As healthy cells may also need to proliferate and avoid apoptosis, anticancer …

Introduction: Despite remarkable advances in tumor treatment, many patients still die from
common tumors (breast, prostate, lung, CNS, colon, and pancreas), and thus, new …

The hypoxic state in a solid tumor refers to the internal hypoxic environment that appears as
the tumor volume increases (the maximum radius exceeds 180-200 microns). This state can …

The gastrin-releasing peptide receptor (BB2r) is overexpressed in a variety of cancers
including prostate cancer. As a consequence, the development of BB2r-targeted …

Imaging plays an important role in prostate cancer (PC), including accurate evaluation of the
extent of disease, assessment of sites of recurrent disease, and monitoring of response to …

Gastrin-releasing peptide receptors (GRPrs) are overexpressed on a variety of human
cancers, providing the opportunity for peptide receptor targeting via radiolabeled bombesin …

Medicines for the treatment of most human pathologies are encumbered by unwanted side
effects that arise from the deposition of an effective drug into the wrong tissues. The logical …

Background The early and accurate detection afforded by imaging techniques significantly
reduces mortality in cancer patients. However, it is still a great challenge to achieve …

Gastrin-releasing peptide receptor (GRPR) is differentially expressed on the surfaces of
various diseased cells, including prostate and lung cancer. However, monitoring temporal …